Literature DB >> 3898487

Altered distribution of class I and class II MHC antigens during acute pancreas allograft rejection in the rat.

B Steiniger, J Klempnauer, K Wonigeit.   

Abstract

The expression of MHC class I and class II antigens was investigated in a model of acute pancreas allograft rejection in the rat. Pancreaticoduodenal and duct-ligated DA(RT1a)-to-LEW(RT1(1] and LEW(RT1(1]-to-LEW.1U(RT1u) pancreas grafts were compared with normal organs and with LEW(RT1(1] isografts at daily intervals from day 1 to day 10 after transplantation. The results show profound changes of MHC antigen distribution in allografts during the process of rejection. Exocrine acinar cells, being class-I-antigen-negative in the normal pancreas, strongly express these antigens during rejection. Class II antigens, normally not found in pancreatic endothelia or parenchymal cells, appear in duct epithelia, acinar cells, and endothelia of big vessels. Endocrine islet cells and smooth muscle cells stay Ia-negative throughout the rejection process. Focal class I reactivity is also observed in acinar cells of pancreaticoduodenal isografts; but class II antigens are neither seen in parenchymal cells nor in endothelia of any isograft. Thus, in the rat pancreas allograft model, the induction of class II antigens is an early phenomenon characteristic of an ongoing immune response, and it provides a valuable new diagnostic criterion. Antibodies reactive exclusively with donor-haplotype antigens demonstrate an increase in donor-derived class I and class II antigen-positive interstitial cells in addition to parenchymal antigenic changes. A possible effect of the antigenic alteration described on the course of the rejection process is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3898487     DOI: 10.1097/00007890-198509000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Identical pattern of acute rejection after isolated islet and vascularized whole-pancreas transplantation in the rat.

Authors:  B Steiniger; W F Hiller; J Klempnauer
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

2.  Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts.

Authors:  R K Sibley; D E Sutherland
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

3.  Class II MHC antigens in the rat digestive system. Normal distribution and induced expression after interferon-gamma treatment in vivo.

Authors:  B Steiniger; P Falk; M Lohmüller; P H van der Meide
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

4.  Distinct histologic patterns of acute, prolonged, and chronic rejection in vascularized rat pancreas allografts.

Authors:  B Steiniger; J Klempnauer
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

5.  Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats.

Authors:  E J Weringer; A A Like
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

6.  The origin of Ia antigen-expressing cells in the rat kidney.

Authors:  A C Gurner; J Smith; V Cattell
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

7.  FasL microgels induce immune acceptance of islet allografts in nonhuman primates.

Authors:  Ji Lei; María M Coronel; Esma S Yolcu; Hongping Deng; Orlando Grimany-Nuno; Michael D Hunckler; Vahap Ulker; Zhihong Yang; Kang M Lee; Alexander Zhang; Hao Luo; Cole W Peters; Zhongliang Zou; Tao Chen; Zhenjuan Wang; Colleen S McCoy; Ivy A Rosales; James F Markmann; Haval Shirwan; Andrés J García
Journal:  Sci Adv       Date:  2022-05-13       Impact factor: 14.957

8.  Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection.

Authors:  R D Forbes; N A Parfrey; M Gomersall; A G Darden; R D Guttmann
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.